Effects of modulation of nitric oxide on acoustic startle responding and prepulse inhibition in rats

European Journal of Pharmacology

Volumn 328, Issue 2-3, 1997, Pages 125-130

  Wiley, Jenny L ^a   Golden, Keith M ^a   Bowen, Scott E ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Nitric oxide (NO); Prepulse inhibition; Schizophrenia; Startle; Startle reaction

Indexed keywords

7 NITROINDAZOLE; ARGININE; DOPAMINE; GLUTAMIC ACID; N(G) NITROARGININE; N(G) NITROARGININE METHYL ESTER; NEUROTRANSMITTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE INHIBITOR; NITROPRUSSIDE SODIUM; PHENCYCLIDINE; PSYCHEDELIC AGENT;

ACOUSTIC REFLEX; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; NONHUMAN; PREPULSE INHIBITION; PRIORITY JOURNAL; RAT; SCHIZOPHRENIA; SENSORIMOTOR FUNCTION; STARTLE REFLEX; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0030900456     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(97)83038-5     Document Type: Article

References (46)

1. Akbarian S., Bunney W.E., Potkin S.G., Wigal S.B., Hagman J.O., Sandman C.A., Jones E.G. Altered distribution of nicotinamide-adenine dinucleotide phosphate-diaphorase cells in frontal lobe of schizophrenics implies disturbances of cortical development. Arch. Gen. Psychiatry. 50:1993;169.
2. Akbarian S., Vinuela A., Kim J.J., Potkin S.G., Bunney W.E., Jones E.G. Distorted distribution of nicotinamide-adenine dinucleotide phosphate-diaphorase neurons in temporal lobe of schizophrenics implies anomalous cortical development. Arch. Gen. Psychiatry. 50:1993;178.
3. Angrist B., Gershon S. The phenomenology of experimentally induced amphetamine psychosis: preliminary observations. Biol. Psychiatry. 2:1970;95.
4. Babey A.-M., Kolesnikov Y., Cheng J., Inturrisi C.E., Trifilletti R.R., Pasternak G.W. Nitric oxide and opioid tolerance. Neuropharmacology. 33:1994;1463.
5. Balster R.L., Mansbach R.S., Shelton K.L., Nicholson K.L., Grech D.M., Wiley J.L., Li H., Weber E. Behavioral pharmacology of two novel substituted quinoxalinedione glutamate antagonists. Behav. Pharmacol. 6:1995;577.
6. Bhargava H. Attenuation of tolerance to, and physical dependence on, morphine in the rat by inhibition of nitric oxide synthase. Gen. Pharmacol. 26:1995;1049.
7. Bohme G.A., Bon C., Lemaire M., Reibaud M., Piot O., Stutzmann J.M., Doble A., Blanchard J.C. Altered synaptic plasticity and memory formation in nitric oxide synthase inhibitor-treated rats. Proc. Natl. Acad. Sci. USA. 90:1993;9191.
8. Braff D., Stone C., Callaway E., Geyer M., Glick I., Bali L. Prestimulus effects on human startle reflex in normals and schizophrenics. Psychophysiology. 15:1978;339.
9. Chapman P.F., Atkins C.M., Allen M.T., Haley J.E., Steinmetz J.E. Inhibition of nitric oxide synthesis impairs two different forms of learning. NeuroReport. 3:1992;567.
10. Connop B.P., Rolfe N.G., Boegman R.J., Jhamandas K., Beninger R.J. Potentiation of NMDA-mediated toxicity on nigrostriatal neurons by a low dose of 7-nitro indazole. Neuropharmacology. 33:1994;1439.
11. Das I., Khan N.S., Puri B.K., Sooranna S.R., De Belleroche J., Hirsch S.R. Elevated platelet calcium mobilization and nitric oxide synthase activity may reflect abnormalities in schizophrenic brain. Biochem. Biophys. Res. Commun. 212:1995;375.
12. De Sarro G.B., Donato di Paola E., De Sarro A., Vidal M.J. Role of nitric oxide in the genesis of excitatory amino acid-induced seizures from the deep prepiriform cortex. Fundam. Clin. Pharmacol. 5:1991;503.
13. Deutsch S.I., Rosse R.B., Paul S.M., Tomasino V., Koetzner L., Morn C.B., Mastropaolo J. 7-Nitroindazole and methylene blue, inhibitors of neuronal nitric oxide synthase and NO-stimulated guanylate cyclase, block MK-801-elicited behaviors in mice. Neuropsychopharmacology. 15:1996;37.
14. Garthwaite J. Glutamate, nitric oxide and cell-cell signalling in the nervous system. Trends Neurosci. 14:1991;60.
15. Geyer M.A., Swerdlow N.R., Mansbach R.S., Braff D.L. Startle response models of sensorimotor gating and habituation deficits in schizophrenia. Brain Res. Bull. 25:1990;485.
16. Hoffman H.S., Ison J.R. Reflex modification in the domain of startle. I. Some empirical findings and their implications for how the nervous system processes sensory input Psychol. Rev. 87:1980;175.
17. Javitt D.C., Zukin S.R. Recent advances in the phencyclidine model of schizophrenia. Am. J. Psychiatry. 148:1991;1301.
18. Jewett D.C., Butelman E.R., Woods J.H. Nitric oxide synthase inhibitors produce phencyclidine-like behavioral effects in pigeons. Brain Res. 715:1996;25.
19. Johansson C., Jackson D.M., Zhang J., Svensson L. Prepulse inhibition of acoustic startle, a measure of sensorimotor gating: effects of antipsychotics and other agents in rats. Pharmacol. Biochem. Behav. 52:1995;649.
20. Karson C.N., Garcia-Rill E., Biedermann J., Mrak R.E., Husain M.M., Skinner R.D. The brain stem reticular formation in schizophrenia. Psychiatry Res. Neuroimaging. 40:1991;31.
21. Khanna J.M., Morato G.S., Shah G., Chau A., Kalant H. Inhibition of nitric oxide synthesis impairs rapid tolerance to ethanol. Brain Res. Bull. 32:1993;43.
22. Kokkinidis L., McCarter B.D. Behavioral evidence implicating dopamine in sensorimotor arousal and norepinephrine in the sedative effects of antidepressant drugs. Psychopharmacology. 100:1990;542.
23. G-Nitro-L-arginine prevents morphine tolerance. Eur. J. Pharmacol. 221:1992;399.
24. Lipton S.A. Prospects for clinically tolerated NMDA antagonists: open-channel blockers and alternative redox states of nitric oxide. Trends Neurosci. 16:1993;527.
25. Lipton S.A., Choi Y.-B., Pan Z.-H., Lel S.Z., Chen H.-S.V., Sucher N.J., Loscaizo J., Singel D.J., Stamler J.S. A redox-based mechanism for the neuroprotective and neurodestructive effects of nitric oxide and related nitroso-compounds. Nature. 364:1993;626.
26. 3H]dopamine release from striatal slices. J. Neurosci. Res. 35:1993;192.
27. MacKenzie G.M., Rose S., Bland-Ward P.A., Moore P.K., Jenner P., Marsden C.D. Time course of inhibition of brain nitric oxide synthase by 7-nitro indazole. NeuroReport. 5:1994;1993.
28. Majeed N.H., Przewlocka B., Machelska H., Przewlocki R. Inhibition of nitric oxide synthase attenuates the development of morphine tolerance and dependence in mice. Neuropharmacology. 33:1994;189.
29. Mansbach R.S. Effects of NMDA receptor ligands on sensorimotor gating in the rat. Eur. J. Pharmacol. 202:1991;61.
30. Manzoni O., Prezeau L., Marin P., Deshager S., Bockaert J., Fagni L. Nitric oxide-induced blockade of NMDA receptors. Neuron. 8:1992;653.
31. Moncada S., Palmer R.M.J., Higgs E.A. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol. Rev. 43:1991;109.
32. Montague P.R., Gancayco C.D., Winn M.J., Marchase R.B., Friedlander M.J. Role of NO production in NMDA receptor-mediated neurotransmitter release in cerebral cortex. Science. 263:1994;973.
33. Nagafusi T., Sugiyama M., Muto A., Makino T., Miyauchi T., Nabata H. The neuroprotective effect of a potent and selective inhibitor of type I NOS (L-MIN) in a rat model of focal cerebral ischaemia. NeuroReport. 6:1995;1541.
34. Paxinos, G., Watson, C., 1986. The Rat Brain in Stereotaxic Coordinates. Academic Press, New York, NY.
35. 3H]dopamine uptake. Brain Res. 641:1994;83.
36. Pudiak C.M., Bozarth M.A. L-NAME and MK-801 attenuate sensitization to the locomotor-stimulating effects of cocaine. Life Sci. 53:1993;1517.
37. Reif D.W. Delayed production of nitric oxide contributes to NMDA-mediated neuronal damage. NeuroReport. 4:1993;566.
38. Rundfeldt C., Koch R., Richter A., Mevissen M., Gerecke U., Loscher W. Dose-dependent anticonvulsant and proconvulsant effects of nitric oxide synthase inhibitors on seizure threshold in a cortical stimulation model in rats. Eur. J. Pharmacol. 274:1995;73.
39. Schulz J.B., Matthews R.T., Muqit M.M.K., Browne S.E., Beal M.F. Inhibition of neuronal nitric oxide synthase by 7-nitroindazole protects against MPTP-induced neurotoxicity in mice. J. Neurochem. 64:1995;936.
40. Stewart J., Deschamps S.E., Amir S. Inhibition of nitric oxide synthase does not block development of sensitization to the behavioral activating effects of amphetamine. Brain Res. 641:1994;141.
41. Vaupel D.B., Kimes A.S., London E.D. Comparison of 7-nitroindazole with other nitric oxide synthase inhibitors as attenuators of opioid withdrawal. Psychopharmacology. 118:1995;361.
42. Volke V., Koks S., Vasar E., Bourin M., Bradwejn J., Mannisto P.T. Inhibition of nitric oxide synthase causes anxiolytic-like behaviour in an elevated plus-maze. NeuroReport. 6:1995;1285.
43. Wiley J.L., Cristello A.F., Balster R.L. Effects of site-selective NMDA receptor antagonists in an elevated plus-maze model of anxiety in mice. Eur. J. Pharmacol. 294:1995;101.
44. Wiley J.L., Golden K.M., Bowen S.E. Effects of modulation of nitric oxide on acoustic startle and prepulse inhibition in rats. Soc. Neurosci. Abstr. 22:1996;1677.
45. Yamada K., Noda Y., Nakayama S., Komori Y., Sugihara H., Hasegawa T., Nabeshima T. Role of nitric oxide in learning and memory and in monoamine metabolism in the rat brain. Br. J. Pharmacol. 115:1995;852.
46. Yamamoto H.A. Nitroprusside intoxication: protection of alpha-ketoglutarate and thiosulphate. Food Chem. Toxicol. 30:1992;887.